System Vaccinology: From Rationale Design to High-Throughput Vaccine Development
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 4550
Special Issue Editor
Special Issue Information
Dear Colleagues,
Vaccine development has evolved from empirical trial-and-error strategies to rational design with the use of big data that reduce time and costs to obtain more effective and safer vaccines. The use of computational tools combined with in vitro methods of screening helps to identify vaccine candidates for further experimentation and anticipate the best immunogens that are likely to induce protective responses. To evaluate the vaccine responses in the discovery phase, systems vaccinology methods can be used to study the mechanism of action of vaccine formulations, in vitro as well as in both experimental animals and clinical studies.
Given the importance and topicality of systems vaccinology and big data in the vaccine development chain, this Special Issue aims to compile a group of works that show the application of bioinformatics and omics techniques at different levels, such as genes, proteins, cells, tissues, and organs, including their interaction with each other, at any stage of vaccine development. All research articles, methodologies, brief communications, reviews, and meta-analyses will be considered to address scientific questions related to these aspects.
We look forward to receiving your contributions.
Dr. Alexander Batista Duharte
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine development
- adjuvants
- antigen prediction
- systems vaccinology
- rationale design
- network analysis
- proteomics
- transcriptomics
- metabolomics
- big data
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
